Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Category: Rheumatology (Oxford)

Press Review…

Winter 2026 Press Review – Rheumatology (Oxford)

18 Jan 2026
August 2025 to November 2025 Author: Hannah den Braanker Long-Term Effects of Selexipag in SSc-Associated Digital Ulcers Iannone et al. (10.1093/rheumatology) evaluated the long-term efficacy of selexipag in treating digital ulcers (DUs)…
Press Review…

Autumn 2025 Press Review – Rheumatology (Oxford)

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Jacob J.E. Koopman ‘Am I doing this right?’ Physician perceptions of the global assessment in clinical trials of systemic sclerosis Sabanovic and colleagues (10.1093/rheumatology/keaf377) interviewed…
Rheumatology (Oxford)

Spring 2025 Press Review – Rheumatology (Oxford)

12 May 2025
December 2024 to March 2025 Authors: Slaverio La Bella & Stephanie Ling Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study Immune checkpoint inhibitors (ICIs)…
Rheumatology (Oxford)

Winter 2025 Press Review – Rheumatology (Oxford)

2 Feb 2025
August 2024 to November 2024 Authors: Milena Bond & Ufuk Ilgen Cancer Risk Factors in Idiopathic Inflammatory Myopathies Tang et al. (10.1093/rheumatology/keae504) validated the International Myositis Assessment and Clinical Studies Group…
Rheumatology (Oxford)

Autumn 2024 Press Review – Rheumatology (Oxford)

8 Oct 202414 Jan 2025
April 2024 to July 2024 Author: Guillermo Carvajal Alegria & Miranda van Lunteren Rheumatology (Oxford) Switching to another mode of action after TNF inhibitors failure in rheumatoid arthritis: data from the…
Rheumatology (Oxford)

Spring 2024 Press Review – Rheumatology (Oxford)

8 May 202410 May 2024
December 2023 to March 2024 Author: Stephanie Ling Rheumatology (Oxford) Higher serum levels of TNF inhibitors in PsA patients with good response Curry et al (doi: 10.1093/rheumatology/kead666) studied 201 patients with…
Press Review…

Winter Press Review 2024 – Rheumatology (Oxford)

10 Jan 2024
August 2023 to November 2023 Authors: Dalifer Freites Nuñez and Alejandro Gómez Gómez Rheumatology (Oxford) Anifrolumab and SLE Yusuke Miyazaki et al. (doi.org/10.1093/rheumatology/kead568) determined the safety and efficacy of anifrolumab in patients…
Press Review…

Autumn 2023 Press Review – Rheumatology

6 Oct 2023
April 2023 to July 2023 Authors: Anastasia Madenidou and Juan Camilo Sarmiento Rheumatology (Oxford) COVID-19 vaccine safety in pregnant and breastfeeding patients with autoimmune disease Andreoli et al. (10.1093/rheumatology/kead382) investigated coronavirus…
EMEUNET…

RHEUMATOLOGY (OXFORD)

13 May 2023
December 2022 to March 2023 Authors: Serena Fasano and Jean-Guillaume Letarouilly Bentley D et al (doi: 10.1093/rheumatology/kead092) explored the efficacy and safety of RO5459072, a Cathepsin S inhibitor, in patients with Sjögren’s syndrome. Patients…
Press Review…

Rheumatology (Oxford)

20 Jan 2023
August to November 2022 Authors: Anastasia Madenidou and Sizheng Steven Zhao Many rheumatologists across the world are trained to prescribe methotrexate (MTX) and folic acid on different days, the latter…

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify
 

Loading Comments...